Market Indices
Sector Heatmap
ERNA — Ernexa Therapeutics Inc. Common Stock
NasdaqErnexa Therapeutics Inc. Common Stock
- O
- 3.00
- H
- 3.28
- L
- 2.90
- V
- 40.71K
ERNA — Latest News & Headlines
10 StoriesAn ovarian cancer model showed 100% survival with a treatment combination. Human testing is planned for early 2027. - stocktitan.net
An ovarian cancer model showed 100% survival with a treatment combination. Human testing is planned for early 2027. stocktitan.net
Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND - markets.businessinsider.com
Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND markets.businessinsider.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session Benzinga
Ernexa (ERNA) director logs zero insider stake in new ownership report - stocktitan.net
Ernexa (ERNA) director logs zero insider stake in new ownership report stocktitan.net
Ernexa completes safety studies for ERNA-101 cancer therapy By Investing.com - Investing.com South Africa
Ernexa completes safety studies for ERNA-101 cancer therapy By Investing.com Investing.com South Africa
CORZ Stock Soars To Record High On Oklahoma Data Center Plan Reaching Gigawatt Scale - Stocktwits
CORZ Stock Soars To Record High On Oklahoma Data Center Plan Reaching Gigawatt Scale Stocktwits
An ovarian cancer study found Ernexa’s cell therapy combo cleared tumors; 100% of animals survived through follow-up. - stocktitan.net
An ovarian cancer study found Ernexa’s cell therapy combo cleared tumors; 100% of animals survived through follow-up. stocktitan.net
Ernexa appoints Robert Spiegel to board, targets IND filing By Investing.com - Investing.com Nigeria
Ernexa appoints Robert Spiegel to board, targets IND filing By Investing.com Investing.com Nigeria
Ernexa completes safety studies for ERNA-101 cancer therapy By Investing.com - Investing.com UK
Ernexa completes safety studies for ERNA-101 cancer therapy By Investing.com Investing.com UK
Ernexa appoints Robert Spiegel to board, targets IND filing By Investing.com - Investing.com UK
Ernexa appoints Robert Spiegel to board, targets IND filing By Investing.com Investing.com UK